Skip to main content

Medication Assisted Treatment - Prescription Drug and Opioid Addiction

This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

 
Catalog of Federal Domestic Assistance Number: 93.243
Sponsors
Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Deadlines
Apr 27, 2021
Contact

For program issues:
Fred Bamfo
240.276.2423
Fred.Bamfo@samhsa.hhs.gov

For grants management and budget issues:
Corey Sullivan
240.276.1213
foacsat@samhsa.hhs.gov

For grant review process and application status questions:
Toni Davidson
240.276.2571
Toni.Davidson@samhsa.hhs.gov

Purpose

The Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA) program provides funding for states, organizations, tribes, and tribal organizations to expand or enhance access to medication assisted treatment (MAT) services for individuals with opioid use disorder (OUD).

Required activities include:

  • Provide MAT using at least one of the FDA-approved medications for the maintenance treatment of OUD
  • Check the state, county, or local Prescription Drug Monitoring Program, where available, for each new patient admission in compliance with any relevant state rules or regulations
  • Conduct screening and assessment for OUD and co-occurring substance use and mental disorders and the delivery or coordination of any services determined to be necessary for the individual patient to achieve and sustain recovery
  • Establish and implement a plan to mitigate the risk of diversion of methadone or buprenorphine and ensure the appropriate use/dose of medication by patients
  • Develop outreach and engagement strategies to increase participation in, and access to, MAT for diverse populations at risk for OUD
  • Build funding mechanisms and service delivery models with rural and resource-limited counties and municipalities
  • Use telehealth services, or other innovative interventions, to reach, engage, and retain clients in treatment
  • Provide recovery support services, including peer recovery support services, designed to improve access to and retention in MAT and facilitate long-term recovery
Eligibility

Eligible applicants are domestic public and private nonprofit entities, including:

  • States
  • Territories
  • Federally recognized American Indian/Alaska Native (AI/AN) tribes
  • Tribal organizations
  • Other public or nonprofit entities
Geographic coverage
Nationwide and U.S. territories
Amount of funding

Award ceiling:

  • $1,000,000 per year for states
  • $525,000 per year for territories, Tribes, Tribal organizations, and other public or nonprofit entities

Project period: Up to 5 years
Estimated number of awards: 89 - 135
Estimated total program funding: $71,322,952

At least $11,000,000 is set aside for federally recognized American Indian/Alaska Native (AI/AN) tribes/tribal organizations if application volume from tribes/tribal organizations permits.

Application process

Links to the full announcement, application instructions, and the online application process are available through grants.gov.

Tagged as
American Indian or Alaska Native · Prescription drug misuse · Substance use and misuse · Telehealth



For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.